Find all School-related info fast with the new School-Specific MBA Forum

It is currently 23 Oct 2014, 07:37

Close

GMAT Club Daily Prep

Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track
Your Progress

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History

Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.

Events & Promotions

Events & Promotions in June
Open Detailed Calendar

Biotechnology companies say that voluntary guideline for

  Question banks Downloads My Bookmarks Reviews Important topics  
Author Message
TAGS:
Senior Manager
Senior Manager
avatar
Joined: 16 Sep 2006
Posts: 406
Followers: 1

Kudos [?]: 12 [0], given: 0

Biotechnology companies say that voluntary guideline for [#permalink] New post 24 Nov 2006, 11:28
00:00
A
B
C
D
E

Difficulty:

(N/A)

Question Stats:

100% (02:49) correct 0% (00:00) wrong based on 1 sessions
1. Biotechnology companies say that voluntary guideline for their industry are sufficient to ensure that no harm will result when a genetically altered organism is released into the environment. It is foolish, however, to rely on assurances from producers of genetically altered organisms that their products will not be harmful. Therefore, a biotechnology company should be required to apply to an independent regulatory board composed of scientists outside the biotechnology industry for the right to sell newly created organisms.
Which one of the following principles, if accepted, most strongly justifies drawing the conclusion above?
(A) Voluntary guidelines are sufficient to regulate activities that pose little danger to the environment.
(B) People who engage in an activity and have a financial stake in that activity should not be the sole regulators of that activity.
(C) Methods that result in harm to the environment must sometimes be used in order to avoid even greater harm.
(D) A company is obligated to ensure the effectiveness of its products but not their environmental safety.
(E) Issues of environmental protection are so important that they should not be left to scientific experts.
Director
Director
avatar
Joined: 28 Dec 2005
Posts: 922
Followers: 2

Kudos [?]: 37 [0], given: 0

 [#permalink] New post 24 Nov 2006, 17:02
B seems to make the most sense. when B is added to the rest of the paragrahp, we can see why the author says that the regulatory body needs to be outside the biotechnology industry
Intern
Intern
avatar
Joined: 23 Aug 2006
Posts: 20
Followers: 0

Kudos [?]: 0 [0], given: 0

 [#permalink] New post 24 Nov 2006, 17:40
One more B here
Manager
Manager
avatar
Joined: 26 Oct 2006
Posts: 127
Followers: 1

Kudos [?]: 0 [0], given: 0

 [#permalink] New post 24 Nov 2006, 19:41
Should'nt it be D. B talks about regulation in general. If D were true then, it calls for an independent external body to regulate environmental aspects of the activies.
Senior Manager
Senior Manager
avatar
Joined: 17 Oct 2006
Posts: 439
Followers: 1

Kudos [?]: 9 [0], given: 0

 [#permalink] New post 25 Nov 2006, 01:30
One more B...
Senior Manager
Senior Manager
avatar
Joined: 19 Jul 2006
Posts: 361
Followers: 1

Kudos [?]: 2 [0], given: 0

 [#permalink] New post 25 Nov 2006, 17:38
D
VP
VP
User avatar
Joined: 21 Aug 2006
Posts: 1026
Followers: 1

Kudos [?]: 19 [0], given: 0

Re: CR on Biotechnology companies !!! [#permalink] New post 25 Nov 2006, 22:46
jyotsnasarabu wrote:
1. Biotechnology companies say that voluntary guideline for their industry are sufficient to ensure that no harm will result when a genetically altered organism is released into the environment. It is foolish, however, to rely on assurances from producers of genetically altered organisms that their products will not be harmful. Therefore, a biotechnology company should be required to apply to an independent regulatory board composed of scientists outside the biotechnology industry for the right to sell newly created organisms.
Which one of the following principles, if accepted, most strongly justifies drawing the conclusion above?
(A) Voluntary guidelines are sufficient to regulate activities that pose little danger to the environment.
(B) People who engage in an activity and have a financial stake in that activity should not be the sole regulators of that activity.

This strengthens the argument.

(C) Methods that result in harm to the environment must sometimes be used in order to avoid even greater harm.
(D) A company is obligated to ensure the effectiveness of its products but not their environmental safety.

This is weakening the conclusion drawn above. For example some research is going on plants' relationship with rhizobium bacteria. As you know, the relationship between a legume crop and bacteria is symbiotic. Bacterial produces nitrogen for its consumption, and its surplus production it shares with the plant in whose root it lives. Though the atomosphere has very highl levels of nitrogen, the plans can't directly take it from air. That is one of the paradoxes of the nanture. That is also one of the reasons nitrogen fertilizers are applied to non-legume crops. To minimize expenses on nitrozen fertilizers and pollution Biotech companies are thinking of new ideas.

Now Biotech companies are conducting research to insert a gene from legume crops into non-legume crops so that they can harbor rhizobium bacteria and have nitrogen for their consumption without the benefit of nitrozen fertilizers. Biotech companies should assure that there wont be any drawbacks from this innovation. What if such genetically modified plants produce toxic substances? The creator has to take care of the responsiblity of its creation. :wink:


(E) Issues of environmental protection are so important that they should not be left to scientific experts.

_________________

The path is long, but self-surrender makes it short;
the way is difficult, but perfect trust makes it easy.

Senior Manager
Senior Manager
User avatar
Joined: 02 Sep 2006
Posts: 256
Followers: 1

Kudos [?]: 11 [0], given: 0

 [#permalink] New post 25 Nov 2006, 23:08
I agree D is wrong.

from the process of elimination, my guess is A.

I think the financial stake issue has nothing to do with the passage. The passage is about genetically altered organisms harmful to the environment. If I am wrong please explain. Thanks.
Senior Manager
Senior Manager
avatar
Joined: 16 Sep 2006
Posts: 406
Followers: 1

Kudos [?]: 12 [0], given: 0

 [#permalink] New post 25 Nov 2006, 23:13
OA=B
  [#permalink] 25 Nov 2006, 23:13
    Similar topics Author Replies Last post
Similar
Topics:
2 Biotechnology companies have invested millions of dollars... avohden 4 13 Oct 2013, 10:11
1 With Emergence of Biotechnology Companies, it was feared Zatarra 4 28 Dec 2010, 06:37
With Emergence of Biotechnology Companies, it was feared amod243 5 04 Sep 2010, 12:13
With the emergence of biotechnology companies, it was feared ritula 4 02 Jun 2008, 23:21
Lark Manufacturing Company initiated a voluntary Quality Janice 3 06 Dec 2004, 19:01
Display posts from previous: Sort by

Biotechnology companies say that voluntary guideline for

  Question banks Downloads My Bookmarks Reviews Important topics  


GMAT Club MBA Forum Home| About| Privacy Policy| Terms and Conditions| GMAT Club Rules| Contact| Sitemap

Powered by phpBB © phpBB Group and phpBB SEO

Kindly note that the GMAT® test is a registered trademark of the Graduate Management Admission Council®, and this site has neither been reviewed nor endorsed by GMAC®.